Good times for UK Life Science Surging energy prices, a cost-of-living crisis, looming stagflation and struggling stock markets: 2022’s financial headlines have seemed almost universally negative. Amidst all this gloom, it should not

The modern Pharma industry has long had issues around “reputation” and much of the criticism has often centred on drug pricing. Commercial organisations developing and selling life changing and life-saving products are held

There is a growing agreement that the key issue facing the global drug industry over the coming years will be how to adapt to a digital landscape that is changing at an astonishing

Like most pharmaceutical companies established in the nineteenth century, Pfizer’s origins are as a fine chemicals company. Charles Pfizer and his cousin established “Charles Pfizer & Company, Manufacturing Chemists in New York in

Change happens quickly in China. On 12th April a Chinese student suffering from cancer posted an angry blog after paying around Rmb200,000 (~GBP20,000) for an (unsuccessful) experimental medical therapy. He found out about

My twin girls are five now and for the past year or so, one of their favourite refrains has been “ask Google, Daddy”. They are at that stage when they are curious about

The buzzword “Multichannel” has been thrown around in pharma marketing circles for a few years now and it has always irked me a little. What marketing isn’t multichannel? Exactly who are these brand

There will probably come a time when many of us will routinely monitor, track and record an array of health metrics on a daily basis. Medicine may start to become an exercise in

Pharmaceutical companies in the US, and elsewhere, have been nervously hovering around the fringes of social media for a number of years now, trying to figure out how to engage with a medium

Industrial strategy has been a key focus for David Cameron’s UK coalition government from day one. Almost the first words uttered by the new Prime Minister in his first major speech1 as leader